PRAVASTATIN ALTER 10 mg TABLETS

Introduction

Package Leaflet: Information for the Patient

Pravastatina Alter 10 mg Tablets EFG

(Pravastatina Sodium)

Read the entire package leaflet carefully before starting to take this medication because it contains important information for you.

• Keep this package leaflet, as you may need to read it again.
• If you have any doubts, consult your doctor or pharmacist.
• This medication has been prescribed to you only and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

1. What is Pravastatina Alter and what is it used for
2. What you need to know before taking Pravastatina Alter
3. How to take Pravastatina Alter
4. Possible side effects
5. Storage of Pravastatina Alter
6. Package Contents and Additional Information

1. What is Pravastatina Alter and what is it used for

Pravastatina Alter belongs to a group of medications known as statins that work by reducing blood lipid, cholesterol, and triglyceride levels.

Pravastatina Alter, in combination with a suitable diet, is indicated in:

• Treatment of primary hypercholesterolemia and mixed dyslipidemia, diseases characterized by increased cholesterol and/or triglycerides in the blood, when diet or other measures (exercise or weight loss) have not been effective.

• Prevention of cardiovascular problems (myocardial infarction) and death from cardiovascular causes in patients with high cholesterol levels and a high risk of suffering a first cardiovascular problem (Primary Prevention).

• Prevention of cardiovascular problems and death from cardiovascular causes in patients with normal or high cholesterol levels who have already had a cardiovascular problem, such as myocardial infarction or angina pectoris (Secondary Prevention).

• Reduction of blood lipid levels in patients undergoing organ transplantation and receiving immunosuppressive treatment.

2. What you need to know before taking Pravastatina Alter

Do not take Pravastatina Alter

• If you are allergic to pravastatina sodium or any of the other components of this medication (listed in section 6).
• If you have any active liver disease (hepatic) or have elevated transaminases (enzymes indicative of liver disease).
• If you are pregnant or may be pregnant.
• If you are breastfeeding.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take Pravastatina Alter:

• If you are taking or have taken in the last 7 days a medication containing fusidic acid (used to treat bacterial infections) orally or by injection. The combination of fusidic acid and Pravastatina Alter can cause serious muscle problems (rhabdomyolysis).

• If you have had any liver disease or have a history of alcoholism.

It is possible that moderate increases in liver transaminase levels may occur, which in most cases return to their initial level without the need to discontinue treatment.

• You should also inform your doctor if you have kidney failure, hypothyroidism, if you have a family history or have previously suffered from muscle disorders, or if you normally consume alcohol.

• During treatment, some patients may experience pain, sensitivity, weakness, or muscle cramps. If you experience any of these symptoms, you should immediately inform your doctor.

• If you have or have had myasthenia (a disease characterized by generalized muscle weakness that can affect the muscles used for breathing) or ocular myasthenia (a disease that causes weakness of the eye muscles), as statins can sometimes worsen the disease or cause myasthenia (see section 4).

It is possible that your doctor may recommend blood tests to determine the condition of your muscles before starting treatment and during treatment, to consider starting, continuing, or discontinuing treatment.

Inform your doctor if you are taking other medications that can also cause muscle disorders, such as:

• Fibrates (lower cholesterol levels).
• Nicotinic acid (lowers cholesterol levels).

Consult your doctor, even if any of the above circumstances have occurred to you at any time.

Consult your doctor or pharmacist before taking Pravastatina Alter if you:

• Have severe respiratory failure.

While you are taking this medication, your doctor will monitor whether you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in the blood, are overweight, and have high blood pressure.

Also, inform your doctor or pharmacist if you experience constant muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.

Taking Pravastatina Alter with other medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

• If you need to take oral fusidic acid to treat a bacterial infection, you will need to stop taking this medication. Your doctor will indicate when you can restart treatment with Pravastatina Alter. The use of Pravastatina Alter with fusidic acid can cause muscle weakness, sensitivity, or pain (rhabdomyolysis). For more information on rhabdomyolysis, see section 4.

Certain medications may interact with Pravastatina Alter; in these cases, it may be necessary to change the dose or interrupt treatment with one of them.

It is essential that you inform your doctor if you are taking or have recently taken any of the following medications:

• Colestyramine or colestipol (can decrease pravastatina levels in the blood) and fibrates (can increase the risk of adverse muscular reactions), which are other medications used to lower cholesterol levels.
• Cyclosporin, a medication used to prevent transplant rejection (given with pravastatina, cyclosporin increases pravastatina levels in the blood).
• Antibiotics such as erythromycin or clarithromycin (can increase pravastatina levels in the blood).
• If you are taking a medication used in the treatment and prevention of blood clot formation called "vitamin K antagonists," inform your doctor before taking pravastatina because the use of vitamin K antagonists concomitantly with pravastatina may increase the results of blood tests used to monitor treatment with vitamin K antagonists.

Taking Pravastatina Alter with food and drinks

Pravastatina Alter can be taken with or without food.

If you regularly drink alcohol, consult your doctor before taking this medication.

Pregnancy, breastfeeding, and fertility

If you are pregnant, breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Pregnancy:

Pravastatina Alter is contraindicated during pregnancy. In case of pregnancy or suspected pregnancy, you should discontinue treatment and inform your doctor as soon as possible.

Breastfeeding:

Pravastatina Alter is contraindicated during the breastfeeding period, as it passes into breast milk.

Driving and using machines

At the recommended doses, Pravastatina Alter does not affect the ability to drive or use machines. However, if you notice symptoms of dizziness, do not drive or use machines until you know how the medication affects you.

Pravastatina Alter contains lactose

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Pravastatina Alter

Follow the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Follow these instructions unless your doctor has given you different instructions.

Remember to take your medication.

Your doctor will indicate the duration of your treatment with Pravastatina Alter. Do not discontinue treatment before.

The tablets should be swallowed with water and can be administered with or without food, preferably at night.

The normal dose is between 10-40 mg once a day. Your doctor will establish the suitable dose for you and make the necessary adjustments based on your response to the medication.

Combined treatment:patients treated with pravastatina and cyclosporin should start treatment with 20 mg of pravastatina once a day; your doctor will adjust the dose up to 40 mg. For patients treated with pravastatina and a bile acid sequestrant (e.g., colestyramine, colestipol), Pravastatina Alter should be administered 1 hour before or 4 hours after the sequestrant.

Children and adolescents (8-18 years) with heterozygous familial hypercholesterolemia:the recommended dose between 8 and 13 years is 10-20 mg once a day, and the recommended dose between 14 and 18 years is 10-40 mg once a day.

Elderly patients:it is not necessary to adjust the dose in these patients unless there are other risk factors.

Patients with renal or hepatic insufficiency:in patients with moderate or severe renal function impairment or significant hepatic function impairment, it is recommended to start treatment with a dose of 10 mg.

If you think the action of Pravastatina Alter is too strong or too weak, inform your doctor or pharmacist.

If you take more Pravastatina Alter than you should

If you have taken more Pravastatina Alter than you should, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.

If you forget to take Pravastatina Alter

In case of forgetting a dose, wait for the next one. Do not take a double dose to make up for the forgotten doses.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Immune system disorders:

Very rare (may affect up to 1 in 10,000 people): allergic reactions, angioedema (swelling of the arms, legs, face, lips, tongue, and/or throat), lupus-like syndrome (inflammation of the skin).

Nervous system disorders:

Uncommon (may affect up to 1 in 100 people): dizziness, headache, sleep disorders, insomnia.

Very rare (may affect up to 1 in 10,000 people): peripheral neuropathy, particularly when used for a prolonged period, and a sensation of tingling.

Frequency not known (frequency cannot be estimated from available data): severe myasthenia (a disease that causes generalized muscle weakness that can affect the muscles used for breathing).

Eye disorders:

Uncommon (may affect up to 1 in 100 people): vision disturbances (including blurred vision and double vision).

Frequency not known (frequency cannot be estimated from available data): ocular myasthenia (a disease that causes weakness of the eye muscles).

Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing.

Gastrointestinal disorders:

Uncommon (may affect up to 1 in 100 people): indigestion/heartburn, abdominal pain, nausea, vomiting, constipation, diarrhea, gas.

Very rare (may affect up to 1 in 10,000 people): pancreatitis (inflammation of the pancreas).

Hepatobiliary disorders:

Very rare (may affect up to 1 in 10,000 people): jaundice (yellowing of the skin), hepatitis (inflammation of the liver), fulminant hepatic necrosis (destruction of liver cells).

Skin and subcutaneous tissue disorders:

Uncommon (may affect up to 1 in 100 people): itching, skin rash, blistering accompanied by itching, hair and scalp abnormalities (including hair loss).

Frequency not known (frequency cannot be estimated from available data): dermatomyositis (a disease characterized by inflammation of the muscles and skin).

Musculoskeletal and connective tissue disorders:

Very rare (may affect up to 1 in 10,000 people): rhabdomyolysis (destruction of muscle fibers), which can be associated with kidney disorders, myopathy (muscle disorders).

Tendon disorders, sometimes complicated by rupture.

Frequency not known (frequency cannot be estimated from available data): muscle rupture.

Renal and urinary disorders:

Uncommon (may affect up to 1 in 100 people): alterations in urine elimination (such as difficulty urinating, urinating more frequently, and urinating more frequently at night).

Reproductive system and breast disorders:

Uncommon (may affect up to 1 in 100 people): sexual disorders.

General disorders:

Uncommon (may affect up to 1 in 100 people): fatigue.

Sleep disorders, including insomnia and nightmares

Memory loss

Sexual dysfunction

Depression

Respiratory problems, including persistent cough and/or difficulty breathing or fever

Diabetes mellitus: the frequency will depend on the presence or absence of risk factors (blood glucose levels in fasting of 5.6 mmol/L, BMI > 30 kg/m2, elevated triglycerides, history of hypertension). Your doctor will monitor you while you are taking this medication.

The following side effects of special clinical interest have also been reported during clinical studies:

Musculoskeletal and connective tissue disorders:

Musculoskeletal pain, including joint pain, muscle cramps, muscle pain (very frequent), muscle weakness (frequent), and elevated creatine kinase levels (enzyme indicative of muscle disorder).

Frequency not known (frequency cannot be estimated from available data): constant muscle weakness.

Hepatic disorders:

Elevations of serum transaminases (enzymes indicative of liver disease).

Reporting of side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Pravastatina Alter

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the packaging. The expiration date is the last day of the month indicated.

Do not store above 30 ºC.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need in the SIGRE Collection Point (or any other medication waste collection system) at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Pravastatina Alter

• The active ingredient is pravastatina sodium. Each tablet contains 10 mg of pravastatina.
• The other components are: Lactose monohydrate, Povidone 30, Magnesium oxide, Microcrystalline cellulose, Sodium croscarmellose, Magnesium stearate.

Appearance of the product and package contents

Pravastatina Alter are white, round, and scored tablets.

The tablet can be divided into equal doses.

They are presented in Al/Al blisters, which are packaged in boxes of 28 tablets.

Marketing Authorization Holder and Manufacturer:

Laboratorios Alter, S.A.

C/ Mateo Inurria 30

28036 Madrid

Spain

Date of the last revision of this package leaflet: April 2024

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/